Wet Age-related Macular Degeneration
Wet Age-related Macular Degeneration (Wet-AMD) also referred to as Neovascular AMD (nAMD), is the most common cause of vision loss among elderly patients in developed countries. Wet-AMD is characterized by abrupt central vision loss caused by abnormal blood vessels that bleed or leak fluid which may swell and damage the macula.
Initially, the fluid causes reversible vision loss but the vision can become irreversible with the progression of time.
DelveInsight offers a brand new inclusion to its newsletter edition that pivots around the Wet Age-related Macular Degeneration market. The newsletter encompasses the complete Wet Age-related Macular Degeneration market landscape, constituting current & ongoing clinical trials, pipeline therapies, marketed and upcoming, novel drugs in the Wet-AMD therapeutic area that are anticipated to transform the Wet-AMD market in the coming years.
Explore more about the details of Wet Age-related Macular Degeneration epidemiological insights, recent news, and happenings, mergers and collaborations, major pharmaceuticals involved, licensing deals along events and top-level conferences expected to occur in the Wet-AMD domain.
Subscribe to our mailing list and stay informed about all the latest developments in the Eye Disorder treatment market.
Download our Newsletter by simply filling up the form towards the right and keep in touch to learn more about our fresh offerings and services.
Also, give it a good read to Wet Age-Related Macular Degeneration: Unravelling the complex disease with comprehensive R&D.
Want to explore more? Visit our info-graphics section to get more insights on the Wet-Age Related Macular Degeneration (Wet AMD) Market.
Know more about What's covered:
- Indication overview
- Signs, symptoms, and diagnosis
- Epidemiological trends
- Treatment approaches
- R&D in the field
- Top conferences
- News Flash
- Recent Research Activities
- Support from International organizations
- Market insights
- Market Dynamics
- Collaborations and deals in the domain
